# FDA Inspection 1201702 - JW Pharmaceutical Corporation - Sihwa Plant - March 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/jw-pharmaceutical-corporation-sihwa-plant/46400ce4-fe9a-44d1-84ad-d2c3ae93f166
Source feed: FDA_Inspections

> FDA Inspection 1201702 for JW Pharmaceutical Corporation - Sihwa Plant on March 17, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201702
- Company Name: JW Pharmaceutical Corporation - Sihwa Plant
- Inspection Date: 2023-03-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/jw-pharmaceutical-corporation-sihwa-plant/ec30f14a-9d0d-44a3-a946-676072d8ebdf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c